Clinical Cell and Gene Therapy (CCGT) Program
KU will be unveiling its Clinical Cell and Gene Therapy (CCGT) Program during Phase 2 of the project. As a cornerstone of modern healthcare, CCGT will stand alongside small molecule drugs, biologics, and medical devices in offering innovative solutions for a wide range of health challenges.
CCGT will hold the promise of restoring balance to the body and potentially curing various conditions.
Our Focus
Cellular Immunotherapies
Harnessing and modifying a patient’s own immune cells to target and fight diseases more effectively.
Gene Therapy
Modifying gene expression and altering cell function to treat or prevent diseases.
Regenerative Medicine
Harnessing the power of stem cells to repair damaged organs and tissues.
Our Focus
Our Goal
Our Goal
At CCGT, we will be committed to delivering innovative, clinical-grade diagnostic and therapeutic solutions for a wide range of diseases and conditions. By collaborating with our Genomics and Precision Medicine Center and our Stem Cells and Advanced Cellular Therapy Center, we will leverage their expertise and resources to advance biotechnology in Jordan.
Get Involved
We are committed to fostering close collaboration with the biopharmaceutical and biotechnology industries to develop groundbreaking therapies that transform patient outcomes. Through these partnerships, we aim to accelerate the future of medicine and drive innovation in the biotechnology sector across the region.